Kohler S

References (2)

Title : S1P receptor antagonists fingolimod and siponimod do not improve the outcome of experimental autoimmune myasthenia gravis mice after disease onset - Pelz_2018_Eur.J.Immunol_48_498
Author(s) : Pelz A , Schaffert H , Diallo R , Hiepe F , Meisel A , Kohler S
Ref : European Journal of Immunology , 48 :498 , 2018
Abstract : Pelz_2018_Eur.J.Immunol_48_498
ESTHER : Pelz_2018_Eur.J.Immunol_48_498
PubMedSearch : Pelz_2018_Eur.J.Immunol_48_498
PubMedID: 29205338

Title : IL-17-producing CD4(+) T cells contribute to the loss of B-cell tolerance in experimental autoimmune myasthenia gravis - Schaffert_2015_Eur.J.Immunol_45_1339
Author(s) : Schaffert H , Pelz A , Saxena A , Losen M , Meisel A , Thiel A , Kohler S
Ref : European Journal of Immunology , 45 :1339 , 2015
Abstract : Schaffert_2015_Eur.J.Immunol_45_1339
ESTHER : Schaffert_2015_Eur.J.Immunol_45_1339
PubMedSearch : Schaffert_2015_Eur.J.Immunol_45_1339
PubMedID: 25676041